English, Article edition: Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective Mattias Neyt; Chris De Laet; Annemieke De Ridder; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/53987
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective
Author
  • Mattias Neyt
  • Chris De Laet
  • Annemieke De Ridder
  • Hans Van Brabandt
Physical Description
  • article
Notes
  • Background There has been a steep increase in the number of percutaneous coronary intervention procedures performed for coronary heart disease since their introduction about 30 years ago. Recently, the use of drug-eluting stents (DES) compared with the original bare metal stents (BMS) has increased in many countries. Abstract: Objective To assess the cost effectiveness of DES versus BMS in a real-world setting from the Belgian healthcare payer perspective. Abstract: Methods We developed a decision analysis model to estimate incremental costs (year 2004 or 2007 values &​lsqb;depending on the underlying variable&​rsqb;) and effectiveness. Incremental effectiveness was calculated by combining relative benefits from published meta-analyses with real-world observations from a Belgian registry. Probabilistic modelling and sensitivity analyses were performed. The model had a 1-year time horizon. Sixteen sub groups were created based on the following characteristics: initial stent type, diabetic status, complex lesion and multi-vessel disease. Scenario analyses were performed for the influence on reinterventions and the duration of clopidogrel use. In each analysis, 1000 Monte Carlo simulations were performed. Abstract: Results The incremental costs for switching from BMS to DES are substantial (approximately €1000), while the benefits, expressed as QALYs, are extremely small (on average <0.001 QALYs gained). This led to very high incremental cost-effectiveness ratios: over €860 000 per QALY gained in all subgroups and scenario analyses. Abstract: Conclusion Comparing DES with BMS, no life-years are gained and small quality-of-life improvements are achieved for short periods, resulting in a high likelihood that DES are not cost effective. When there is competition for scarce resources this should be considered when deciding on the reimbursement of this technology.
  • RePEc:wkh:phecon:v:27:y:2009:i:4:p:313-327
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment